Company Overview and News


Add DXB
to your dashboard

Headline News

Dimerix appoints Kathy Harrison inaugural full time CEO

2017-08-01 proactiveinvestors.com.au
Dimerix Ltd (ASX:DXB) has promoted Kathy Harrison to the inaugural full time chief executive officer of the company.

Dimerix Ltd's valuation more than doubles after Kathy Harrison delivers results

2017-07-19 proactiveinvestors.com.au
Dimerix Ltd's (ASX:DXB) shares continue to rally on the back of positive results from its Phase 2a Trial of DMX-200 in Chronic Kidney Disease (CKD).

Dimerix Ltd's shares rally on positive results from clinical trial

2017-07-12 proactiveinvestors.com.au
Dimerix Ltd (ASX:DXB) shares have rallied 18% in morning trade to $0.013, following the company revealing positive results from its Phase 2a Trial of DMX-200 in Chronic Kidney Disease (CKD).

Dimerix Ltd to reveal Phase 2 trial results on Chronic Kidney Disease

2017-07-11 proactiveinvestors.com.au
Dimerix Ltd (ASX:DXB) is preparing to take investors through the results of its Phase 2 trial results on Chronic Kidney Disease, with the ASX granting the company a trading halt to prepare.

Dimerix hosts key U.S. meetings ahead of final clinical data

2017-06-06 proactiveinvestors.com.au
Dimerix (ASX:DXB) has key news flow pending as it remains on-track to release final clinical data for its Phase 2 Dose Escalation study in chronic kidney disease in July.

Dimerix: Access latest PPT from Proactive's CEO Sessions

2017-04-13 proactiveinvestors.com.au
Dimerix’ (ASX:DXB) chief executive officer, Kathy Harrison, joined Proactive's CEO Sessions in Melbourne on Tuesday, 11th April and Sydney on Wednesday, 12th April.

Dimerix brings Phase II clinical trials to Proactive's Spotlight CEO Sessions

2017-04-03 proactiveinvestors.com.au
Dimerix (ASX:DXB) is a clinical stage biotechnology company, with a focus on Phase II clinical trials for chronic kidney disease.

Proteomics International to outline pathway to market at Proactive's CEO Sessions

2017-03-27 proactiveinvestors.com.au
The company continues on a path to commercialisation as it advances deals with partners in Singapore and China to bring its PromarkerD, which is patented in both countries, to the Asian market.

Southern Gold brings gold production to Proactive's Spotlight CEO Sessions

2017-03-27 proactiveinvestors.com.au
Southern Gold (ASX:SAU) is an under the radar company producing gold near Kalgoorlie through ore agreements with Westgold Resources (ASX:WGX).

Dimerix receives cash injection from tax refund

2017-03-23 proactiveinvestors.com.au
Dimerix (ASX:DXB) has received $421,549 cash as part of the federal government research and development tax incentive program.

Dimerix Bioscience Ltd surges in chronic kidney disease clinical trial

2016-06-06 proactiveinvestors.com.au
Dimerix Bioscience Ltd (ASX:DXB) is a biotechnology company advancing new drug therapies through the clinic for unmet medical needs.

Appendix 4C - quarterly

2016-04-29 asx.com.au

Appendix 3B

2016-04-28 asx.com.au

Stocks Digital Q&A

2016-03-30 asx.com.au

Wholesale Investor Presentation

2016-02-25 asx.com.au

Change in substantial holding

2016-02-24 asx.com.au

Change in substantial holding

2016-02-24 asx.com.au

Half Yearly Report and Accounts

2016-02-24 asx.com.au